Studies on Age-Dependent Plasma Platinum Pharmacokinetics and Ototoxicity of Cisplatin
- 1 January 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in Selective Cancer Therapeutics
- Vol. 6 (3), 145-151
- https://doi.org/10.1089/sct.1990.6.145
Abstract
The age-related difference of cisplatin (CDDP) pharmacokinetics and ototoxicity were studied in 6 children with solid tumors who received CDDP infusion. CDDP was administered intravenously for 6 hours at a dosage of 30-120 mg/m2 and plasma-free platinum concentrations were determined by atomic absorption spectrophotometry. Plasma-free platinum concentrations ranged from 1.0 to 2.1 μg/ml at the end of infusions and declined rapidly with T1/2 of 0.6∼1.5 hours. Pharmacokinetic parameters of plasma-free platinum were analyzed in 13 CDDP infusions by the one-compartment open model method. Parameters (Ke, cl, T1/2 and Vd) of free platinum pharmacokinetics were 0.66hr−1, 7.71l/hr, 1.35 hr and 15.71l in the younger group (age: 1.7-6.5 years old) and 1.44 hr−1, 11.41l /hr, 0.61 hr and 8.99l in the older group (age: 12.2-15.7 years old), respectively. Up to 600mg/m2 of the cumulative dosage of CDDP caused minimal ototoxicity in the older group; however, in the younger group, hearing loss at a high frequency zone (6000 and 8000 Hz) began to appear at a cumulative dosage of 200 mg/m2 and progressed to middle zone (3000 Hz) when dosages surpassed 400mg/m2. These data indicate that the pharmacokinetic difference in age possesses a large distribution volume (Vd) and that slower elimination of the drug in a younger age group is an important factor for age-dependent ototoxicity.Keywords
This publication has 7 references indexed in Scilit:
- A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.Journal of Clinical Oncology, 1989
- Cisplatin in recurrent pediatric brain tumors A pog phase II study a pediatric oncology group studyCancer, 1985
- Hearing loss in children receiving cisplatin chemotherapyThe Journal of Pediatrics, 1983
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancerCancer Chemotherapy and Pharmacology, 1982
- Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicityCancer, 1981
- Cisplatin disposition in children and adolescents with cancerCancer Chemotherapy and Pharmacology, 1981